Postmenopausal Diseases and Disorders (2019)

個数:

Postmenopausal Diseases and Disorders (2019)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 484 p.
  • 言語 ENG
  • 商品コード 9783030139384
  • DDC分類 618.175

Full Description

Supported by the latest scientific data, this book serves as a guide to the clinical assessment of women's health during the second half of life (post-reproductive years), including approaches to the management of the most frequent age-related diseases and disorders and the most recent advances in treatment. In addition, it discusses preventive aspects of healthcare in post-reproductive women, identifying lifestyle measures to enhance healthy aging. By highlighting research gaps, it promotes the development of quick and easy-to-use assessment tools and predictive markers of age-related co-morbidities. As such, the book is a valuable resource for researchers and clinicians alike. 

Contents

Chapter 1: Assisted Reproductive Technology in Peri- and postmenopausal Women.- Chapter 2: Turner Syndrome: Primary Amenorrhea from Adolescence to Ageing.- Chapter 3: Premature Ovarian Insufficiency.- Chapter 4: Human Papilloma Virus Infection and Cancer Risk in Peri- and postmenopausal Women.- Chapter 5: Risk and Protective Factors for Sporadic Ovarian and Fallopian Tube Cancer in Postmenopausal Women.- Chapter 6: Vulvar Dermatoses and Menopause.- Chapter 7: Bladder Pain Syndrome/Interstitial Cystitis.- Chapter 8: Overactive Bladder.- Chapter 9: Management of Female Stress Urinary Incontinence.- Chapter 10: Screening and Management of Female Sexual Dysfunction During the Second Half of Life.- Chapter 11: Current Treatment Modalities for the Genitourinary Syndrome of Menopause.- Chapter 12: Laser Treatment for Vulvovaginal Atrophy.- Chapter 13: Laser Treatments in Female Urinary Incontinence.- Chapter 14: Metabolic Syndrome and Excessive Body Weight in Peri- and postmenopausal Women.- Chapter 15: Metabolic Syndrome and Atherosclerosis in Non-diabetic Postmenopausal Women.- Chapter 16: Polycystic Ovary Syndrome related Risks in Postmenopausal Women.- Chapter 17: Sleep and Sleep Disturbances in Climacteric Women.- Chapter 18: Impact of Menopause on Brain Functions.- Chapter 19: Vasomotor Symptoms: Clinical Management.- Chapter 20: Vasomotor Symptoms, Metabolic Syndrome and Cardiovascular Risks.- Chapter 21: A Woman's Heart Needs Her Hormones.- Chapter 22: Menopause Hormone Therapy to Prevent Chronic Conditions.- Chapter 23: Selective Estrogen Receptor Modulators (SERMs): State of the Art.- Chapter 24: Management of Osteoporosis in Postmenopausal Women.- Chapter 25: Anabolic Agents for the Treatment of Postmenopausal Osteoporosis.- Chapter 26: The Links Between Osteoporosis and Sarcopenia in Women.- Chapter 27: Female Sarcopenic Obesity.- Chapter 28: Cognitive Decline in Women: The Zarademp Study.- Chapter 29: Managing Menopause and Post-reproductive Health: Beyond Hormones and Medicines.- Chapter 30: Effect of Exercise on Menopausal Prevalent Conditions.

最近チェックした商品